Flucelvax Trivalent 2024-2025 is an injectable vaccine that protects in opposition to three strains of the influenza virus. It’s permitted to be used in individuals 6 months of age and older.
Flucelvax Trivalent 2024-2025 is made utilizing a cell culture-based manufacturing technique. Because of this the vaccine is produced in a managed surroundings utilizing mammalian cells. This technique is extra environment friendly and cheaper than conventional egg-based manufacturing strategies.
Flucelvax Trivalent 2024-2025 has been proven to be protected and efficient in scientific trials. It’s well-tolerated, with the commonest unintended effects being injection website ache, redness, and swelling.